Johnson & Johnson (NYSE:JNJ) has recalled Infant’s Tylenol in US due to bottle design problems.

Johnson & Johnson Makes US Tylenol Recall

The pharmaceutical company Johnson & Johnson (NYSE:JNJ) has recalled 574,000 bottles of grape-flavored, liquid Infant’s Tylenol from the US market due to complaints about its bottle design.

The company introduced Infant’s Tylenol three months ago claiming to have made big safety improvements to making measuring doses more accurate.

However, parents complained that when they inserted the syringe into the bottle, it also pushed the protective cover inside.

Johnson & Johnson (NYSE:JNJ) CEO William Weldon said, “Today’s news about the Infant’s Tylenol recall is clearly disappointing after all the progress that McNeil has been making to ensure its products meet the highest level of quality and consumer satisfaction”.

Johnson & Johnson (NYSE:JNJ) stocks were at 64.99 at the end of the last day’s trading. There’s been a 1.8% movement in the stock price over the past 3 months.

Johnson & Johnson (NYSE:JNJ) Analyst Advice
Consensus Opinion: Moderate Buy
Mean recommendation: 2
(1=Strong Buy, 5=Strong Sell)
3 Months Ago: 1.95
Zack’s Rank: 2 out of 14 in the industry